Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fos-transformation activates genes associated with invasion.
Hennigan RF, Hawker KL, Ozanne BW. Hennigan RF, et al. Oncogene. 1994 Dec;9(12):3591-600. Oncogene. 1994. PMID: 7970719
Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro.
Sherman L, Sleeman JP, Hennigan RF, Herrlich P, Ratner N. Sherman L, et al. Among authors: hennigan rf. Oncogene. 1999 Nov 18;18(48):6692-9. doi: 10.1038/sj.onc.1203055. Oncogene. 1999. PMID: 10597275
Invasion is a genetic program regulated by transcription factors.
Ozanne BW, Spence HJ, McGarry LC, Hennigan RF. Ozanne BW, et al. Among authors: hennigan rf. Curr Opin Genet Dev. 2006 Feb;16(1):65-70. doi: 10.1016/j.gde.2005.12.012. Epub 2005 Dec 27. Curr Opin Genet Dev. 2006. PMID: 16377173 Review.
Transcription factors control invasion: AP-1 the first among equals.
Ozanne BW, Spence HJ, McGarry LC, Hennigan RF. Ozanne BW, et al. Among authors: hennigan rf. Oncogene. 2007 Jan 4;26(1):1-10. doi: 10.1038/sj.onc.1209759. Epub 2006 Jun 26. Oncogene. 2007. PMID: 16799638 Review.
AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44.
Lamb RF, Hennigan RF, Turnbull K, Katsanakis KD, MacKenzie ED, Birnie GD, Ozanne BW. Lamb RF, et al. Among authors: hennigan rf. Mol Cell Biol. 1997 Feb;17(2):963-76. doi: 10.1128/mcb.17.2.963. Mol Cell Biol. 1997. PMID: 9001250 Free PMC article.
Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.
Hawker KL, Pintzas A, Hennigan RF, Gillespie DA, Ozanne BW. Hawker KL, et al. Among authors: hennigan rf. J Virol. 1993 Sep;67(9):5487-95. doi: 10.1128/JVI.67.9.5487-5495.1993. J Virol. 1993. PMID: 8350408 Free PMC article.
A 5'-distal enhanceosome in the PDGF-A gene is activated in choriocarcinoma cells via ligand-independent binding of vitamin D receptor and constitutive jun kinase signaling.
Pedigo NG, Zhang H, Bruno ME, Kaetzel CS, Dugan AR, Shanehsaz P, Hennigan RF, Xing Z, Koszewski NJ, Kaetzel DM. Pedigo NG, et al. Among authors: hennigan rf. Oncogene. 2005 Apr 14;24(16):2654-66. doi: 10.1038/sj.onc.1208336. Oncogene. 2005. PMID: 15829977
The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway.
Hennigan RF, Moon CA, Parysek LM, Monk KR, Morfini G, Berth S, Brady S, Ratner N. Hennigan RF, et al. Oncogene. 2013 Feb 28;32(9):1135-43. doi: 10.1038/onc.2012.135. Epub 2012 Apr 23. Oncogene. 2013. PMID: 22525268 Free PMC article.
NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation.
Bosco EE, Nakai Y, Hennigan RF, Ratner N, Zheng Y. Bosco EE, et al. Among authors: hennigan rf. Oncogene. 2010 Apr 29;29(17):2540-9. doi: 10.1038/onc.2010.20. Epub 2010 Feb 15. Oncogene. 2010. PMID: 20154721 Free PMC article.
Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.
Lepont P, Stickney JT, Foster LA, Meng JJ, Hennigan RF, Ip W. Lepont P, et al. Among authors: hennigan rf. Mutat Res. 2008 Jan 1;637(1-2):142-51. doi: 10.1016/j.mrfmmm.2007.07.015. Epub 2007 Aug 6. Mutat Res. 2008. PMID: 17868749 Free PMC article.
32 results
Jump to page